Last Posted: Jun 22, 2017
Acceptance of adjuvant chemotherapy recommendations in early-stage hormone-positive breast cancer.
Marcinkowski Emily F et al. The Journal of surgical research 2017 Jun 21479-85
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer.
McVeigh Terri P et al. Breast cancer (Dove Medical Press) 2017 9393-400
Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature.
El Hage Chehade Hiba et al. American journal of surgery 2017 Jun
PARP Inhibitor for Metastatic Breast Cancer
NEJM Journal Watch, June 14, 20
Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study.
Jones Tarsha et al. Cancer medicine 2017 Jun
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment.
Liede Alexander et al. Breast cancer research and treatment 2017 Jun
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.